Skip to main content
. 2009 Nov 30;54(2):749–756. doi: 10.1128/AAC.01101-09

FIG. 5.

FIG. 5.

Representative liver immunohistochemistry for HBcAg expression in bortezomib-treated mice. (A) A control section of human liver from an HBV-positive patient revealed numerous HBV-positive hepatocytes with strong cytoplasmic and nuclear staining (arrowheads). (B and C) There was no significant difference in the number and distribution of HBV-positive hepatocytes (arrowheads) in HBV-infected mice 1 day after intravenous injection of saline (B) or 1 mg/kg bortezomib (C). Bars, 100 μm.